ATE425731T1 - Pharmazeutische zusammensetzungen eines nichtmagensaftresistenten protonenpumpen-hemmers mit einer carbonat- und bicarbonatsalzkombination - Google Patents

Pharmazeutische zusammensetzungen eines nichtmagensaftresistenten protonenpumpen-hemmers mit einer carbonat- und bicarbonatsalzkombination

Info

Publication number: ATE425731T1
Authority: AT; Austria
Prior art keywords: proton pump; pump inhibitor; carbonate; salt; metal
Prior art date: 2000-12-28

Application number

AT01991084T

Other languages

English (en)

Inventor

Rajneesh Taneja

Pramod Gupta

Original Assignee

Tap Pharmaceutical Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-12-28

Filing date

2001-12-12

Publication date

2009-04-15

2001-12-12 Application filed by Tap Pharmaceutical Prod Inc filed Critical Tap Pharmaceutical Prod Inc

2009-04-15 Application granted granted Critical

2009-04-15 Publication of ATE425731T1 publication Critical patent/ATE425731T1/de

Links

229940126409 proton pump inhibitor Drugs 0.000 title abstract 5
239000000612 proton pump inhibitor Substances 0.000 title abstract 5
BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 title abstract 4
239000008194 pharmaceutical composition Substances 0.000 title abstract 2
BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 title 1
229910052751 metal Inorganic materials 0.000 abstract 4
239000002184 metal Substances 0.000 abstract 4
150000005323 carbonate salts Chemical class 0.000 abstract 3
239000000203 mixture Substances 0.000 abstract 3
CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical group [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 abstract 2
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 abstract 2
239000003937 drug carrier Substances 0.000 abstract 2
238000009472 formulation Methods 0.000 abstract 2
206010015137 Eructation Diseases 0.000 abstract 1
UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical group [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 abstract 1
208000027687 belching Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
210000004211 gastric acid Anatomy 0.000 abstract 1
229960003174 lansoprazole Drugs 0.000 abstract 1
MJIHNNLFOKEZEW-UHFFFAOYSA-N lansoprazole Chemical compound CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC=CC=C2N1 MJIHNNLFOKEZEW-UHFFFAOYSA-N 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
229910000030 sodium bicarbonate Inorganic materials 0.000 abstract 1
235000017557 sodium bicarbonate Nutrition 0.000 abstract 1
229910000029 sodium carbonate Inorganic materials 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Inorganic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Plural Heterocyclic Compounds (AREA)

AT01991084T 2000-12-28 2001-12-12 Pharmazeutische zusammensetzungen eines nichtmagensaftresistenten protonenpumpen-hemmers mit einer carbonat- und bicarbonatsalzkombination ATE425731T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US75043000A	2000-12-28	2000-12-28

Publications (1)

Publication Number	Publication Date
ATE425731T1 true ATE425731T1 (de)	2009-04-15

Family

ID=25017841

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT01991084T ATE425731T1 (de)	2000-12-28	2001-12-12	Pharmazeutische zusammensetzungen eines nichtmagensaftresistenten protonenpumpen-hemmers mit einer carbonat- und bicarbonatsalzkombination

Country Status (7)

Country	Link
EP (1)	EP1353624B1 (de)
JP (1)	JP2004525100A (de)
AT (1)	ATE425731T1 (de)
CA (1)	CA2432184A1 (de)
DE (1)	DE60138044D1 (de)
MX (1)	MXPA03005384A (de)
WO (1)	WO2002053097A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6699885B2 (en) *	1996-01-04	2004-03-02	The Curators Of The University Of Missouri	Substituted benzimidazole dosage forms and methods of using same
US5840737A (en)	1996-01-04	1998-11-24	The Curators Of The University Of Missouri	Omeprazole solution and method for using same
EP1492511B3 (de)	2002-04-09	2012-05-02	Flamel Technologies	Orale wässrige suspension, mikrokapseln enthaltend, zur kontrollierten freisetzung von wirkstoffen
US8993599B2 (en)	2003-07-18	2015-03-31	Santarus, Inc.	Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en)	2004-05-25	2014-12-09	Santarus, Inc.	Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CA2582300A1 (en) *	2004-10-05	2006-04-13	Altana Pharma Ag	Oral pharmaceutical preparation comprising a proton pump antagonist and a basic excipient

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH05194225A (ja) *	1991-11-07	1993-08-03	Yoshitomi Pharmaceut Ind Ltd	安定化された抗潰瘍剤含有製剤
US5840737A (en) *	1996-01-04	1998-11-24	The Curators Of The University Of Missouri	Omeprazole solution and method for using same
US5750104A (en) *	1996-05-29	1998-05-12	Digestive Care Inc.	High buffer-containing enteric coating digestive enzyme bile acid compositions and method of treating digestive disorders therewith
JP4127740B2 (ja) *	1998-04-20	2008-07-30	エーザイ・アール・アンド・ディー・マネジメント株式会社	安定化したベンズイミダゾール系化合物含有組成物
AU6087100A (en) *	1999-07-12	2001-01-30	Smithkline Beecham Corporation	Heartburn treatment

2001
- 2001-12-12 EP EP01991084A patent/EP1353624B1/de not_active Expired - Lifetime
- 2001-12-12 AT AT01991084T patent/ATE425731T1/de not_active IP Right Cessation
- 2001-12-12 MX MXPA03005384A patent/MXPA03005384A/es not_active Application Discontinuation
- 2001-12-12 CA CA002432184A patent/CA2432184A1/en not_active Abandoned
- 2001-12-12 DE DE60138044T patent/DE60138044D1/de not_active Expired - Fee Related
- 2001-12-12 WO PCT/US2001/048320 patent/WO2002053097A2/en not_active Ceased
- 2001-12-12 JP JP2002554048A patent/JP2004525100A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
WO2002053097A2 (en)	2002-07-11
EP1353624A4 (de)	2004-07-21
EP1353624B1 (de)	2009-03-18
JP2004525100A (ja)	2004-08-19
CA2432184A1 (en)	2002-07-11
WO2002053097A3 (en)	2003-01-30
EP1353624A2 (de)	2003-10-22
MXPA03005384A (es)	2004-05-05
DE60138044D1 (de)	2009-04-30

Similar Documents

Publication	Publication Date	Title
DE69626117D1 (de)	2003-03-13	Orale pharmazeutische zusammensetzungen mit verzögerter freisetzung von reversiblen protonpumpen-inhibitoren
ATE324872T1 (de)	2006-06-15	Orale pharmazeutische zusammensetzung mit verzögerter wirkstofffreigabe von protonenpumpen- hemmern
BRPI0015567B8 (pt)	2021-05-25	composto, composição farmacêutica, forma de unidade de dosagem, uso da composição farmacêutica e método para preparar uma composição farmacêutica
EP1022026A3 (de)	2002-04-10	Zusammenstellungen zur Behandlung von Nitrat-induzierter Toleranz
CO5580776A2 (es)	2005-11-30	Formulacion farmaceutica estable en solucion de oxaliplatino
IS4146A (is)	1994-10-31	Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara
WO2004066910A8 (en)	2004-10-07	Controlled release modifying complex and pharmaceutical compositions thereof
SE0101379D0 (sv)	2001-04-18	Komposition som hämmar utsöndring av magsyra
ATE151285T1 (de)	1997-04-15	Orale arzneimittel mit kolonspezifischer freisetzung
DE69403656D1 (de)	1997-07-10	Stabile, orale und absorbierbare therapeutische zusammensetzungen von nadh und nadph
AU2001296865A1 (en)	2002-03-22	(5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
BR0207872A (pt)	2004-06-22	Composto para liberar agentes ativos, composição, forma de unidade de dosagem e método de administração
WO2004062561A3 (en)	2004-10-07	Pharmaceutical compositions comprising fentanyl for intranasal delivery
DK1121127T3 (da)	2005-05-02	Orale farmaceutiske sammensætninger, som indeholder buprenorphin
ID28510A (id)	2001-05-31	Formulasi oral yang baru untuk agonis atau antagonis 5-ht4
AP2003002763A0 (en)	2003-03-31	Controlled release formulations for oral administration
DK1269860T3 (da)	2005-12-19	Farmaceutisk præparat
NO996049D0 (no)	1999-12-08	Kontrollert-frigjøring farmasoeytisk preparat med ACE inhibitor som aktivt middel
ATE425731T1 (de)	2009-04-15	Pharmazeutische zusammensetzungen eines nichtmagensaftresistenten protonenpumpen-hemmers mit einer carbonat- und bicarbonatsalzkombination
ATE367153T1 (de)	2007-08-15	Multipartikuläre arzneizusammensetzungen mit gesteuerter wirkstoffabgabe enthaltend selektive inhibitoren der serotoninwiederaufnahme
ES2150404T3 (es)	2003-07-01	Composiciones farmaceuticas de tizoxanida y nitozoxanida.
NZ523606A (en)	2004-12-24	Pharmaceutical compositions and methods for use
DK0799618T3 (da)	2005-05-30	Anvendelse af alpha1-adrenoreceptor-antagonister i fremstillingen af et medikament til forebyggelsen og behandlingen af cancer
WO2000026185A3 (en)	2000-08-10	Omeprazole solution and method of using same
BR0307319A (pt)	2005-01-04	Forma de dosagem oral para liberação controlada de droga

Legal Events

Date	Code	Title	Description
2009-09-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties